肽核酸，類肽和多肽定制合成服務(wù)以及肽核酸單體，類肽單體
普通會員
產(chǎn)品價格面議
產(chǎn)品品牌賽曼諾生物
最小起訂≥5 mg
供貨總量1000 mg
發(fā)貨期限自買家付款之日起 3 天內(nèi)發(fā)貨
瀏覽次數(shù)53
企業(yè)旺鋪http://cellmano.sjooo.com/
更新日期2015-02-06 13:44
會員級別：企業(yè)會員
已 繳 納：0.00 元保證金
我的勛章： [誠信檔案]
在線客服：
企業(yè)二維碼： 企業(yè)名稱加二維碼
品牌： |
賽曼諾生物 |
所在地： |
安徽 合肥市 |
起訂： |
≥5 mg |
供貨總量： |
1000 mg |
有效期至： |
長期有效 |
| (D-Arg1,D-Pro2,D-Trp7·9,Leu11)-Substance P | C75H108N20O13 | 1497.81 | 84676-91-5 | H-D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 |
| (D-Arg1,D-Trp5·7·9,Leu11)-Substance P | C81H110N20O12 | 1555.89 | H-D-Arg-Pro-Lys-Pro-D-Trp-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | |
| (D-Arg1,D-Trp7·9,Leu11)-Substance P, Spantide I | C75H108N20O13 | 1497.81 | 91224-37-2 | H-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 |
| (D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7,β-(3-pyridyl)-D-Ala9,Nle11)-Substance P, Spantide III | C83H102Cl2N18O13 | 1630.74 | 154427-06-2 | H-D-Lys(nicotinoyl)-Pro-β-(3-pyridyl)-Ala-Pro-3,4-dichloro-D-Phe-Asn-D-Trp-Phe-β-(3-pyridyl)-D-Ala-Leu-Nle-NH2 |
| (D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7·9,Nle11)-Substance P, Spantide II | C86H104Cl2N18O13 | 1668.79 | 129176-97-2 | H-D-Lys(nicotinoyl)-Pro-β-(3-pyridyl)-Ala-Pro-3,4-dichloro-D-Phe-Asn-D-Trp-Phe-D-Trp-Leu-Nle-NH2 |
| (D-Pro2,D-Phe7,D-Trp9)-Substance P | C72H105N19O13S | 1476.81 | 77275-70-8 | H-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Phe-Phe-D-Trp-Leu-Met-NH2 |
| (D-Pro2,D-Trp7·9)-Substance P | C74H106N20O13S | 1515.85 | 80434-86-2 | H-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Met-NH2 |
| (D-Pro4,D-Trp7·9·10)-Substance P (4-11), Gpant-1, Ptt-SP (4-11) | C62H74N14O10S | 1207.42 | 86917-57-9 | H-D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2 |
| (D-Pro4,D-Trp7·9,Nle11)-Substance P (4-11) | C58H77N13O10 | 1116.33 | 89430-34-2 | H-D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Nle-NH2 |
| (D-Pro4,D-Trp7·9·10,Val8)-Substance P (4-11), Pvt-SP (4-11) | C58H74N14O10S | 1159.38 | 86917-56-8 | H-D-Pro-Gln-Gln-D-Trp-Val-D-Trp-D-Trp-Met-NH2 |
| (Arg6,D-Trp7·9,N-Me-Phe8)-Substance P (6-11) | C49H66N12O6S | 951.21 | 115150-59-9 | H-Arg-D-Trp-N-Me-Phe-D-Trp-Leu-Met-NH2 |
| (Tyr6,D-Phe7,D-His9)-Substance P (6-11), Sendide | C44H57N9O7S | 856.06 | 145194-26-9 | H-Tyr-D-Phe-Phe-D-His-Leu-Met-NH2 |
| Synaptobrevin-2 (73-79) (human, bovine, mouse, rat), Vesicle-Associated Membrane Protein 2 (73-79) (human, bovine, mouse, rat), VAMP-2 (73-79) (human, bovine, mouse, rat) | C32H48N8O14 | 768.78 | 401933-00-4 | H-Ala-Ser-Gln-Phe-Glu-Thr-Ser-OH |
| Synaptobrevin-2 (75-78) (human, bovine, mouse, rat), Vesicle-Associated Membrane Protein 2 (75-78) (human, bovine, mouse, rat), VAMP-2 (75-78) (human, bovine, mouse, rat) | C23H33N5O9 | 523.54 | H-Gln-Phe-Glu-Thr-OH | |
| Syndyphalin SD-33 | C25H34N4O5S | 502.63 | 87636-57-5 | H-Tyr-D-Met(O)-Gly-N-Me-phenylethylamide |
| Iberiotoxin | C179H274N50O55S7 | 4230.91 | 129203-60-7 | Pyr-Phe-Thr-Asp-Val-Asp-Cys-Ser-Val-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Lys-Asp-Leu-Phe-Gly-Val-Asp-Arg-Gly-Lys-Cys-Met-Gly-Lys-Lys-Cys-Arg-Cys-Tyr-Gln-OH (Disulfide bonds between Cys? and Cys²?/Cys¹³ and Cys³³/Cys¹? and Cys³?) |
| Kaliotoxin | C171H283N55O49S8 | 4150.01 | 145199-73-1 | H-Gly-Val-Glu-Ile-Asn-Val-Lys-Cys-Ser-Gly-Ser-Pro-Gln-Cys-Leu-Lys-Pro-Cys-Lys-Asp-Ala-Gly-Met-Arg-Phe-Gly-Lys-Cys-Met-Asn-Arg-Lys-Cys-His-Cys-Thr-Pro-Lys-OH (Disulfide bonds between Cys? and Cys²?/Cys¹? and Cys³³/Cys¹? and Cys³?) |
| Margatoxin | C178H286N52O50S7 | 4179.01 | 145808-47-5 | H-Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Leu-Pro-Pro-Cys-Lys-Ala-Gln-Phe-Gly-Gln-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro-His-OH (Disulfide bonds between Cys? and Cys²?/Cys¹³ and Cys³?/Cys¹? and Cys³?) |
| Noxiustoxin | C174H286N52O54S7 | 4194.97 | 143074-44-6 | H-Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Ser-Lys-Pro-Cys-Lys-Glu-Leu-Tyr-Gly-Ser-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Asn-Asn-NH2 (Disulfide bonds between Cys? and Cys²?/Cys¹³ and Cys³?/Cys¹? and Cys³?) |
| Suc-Ala-Gln-Pro-Phe-pNA | C32H39N7O10 | 681.7 | 128822-33-3 | Suc-Ala-Gln-Pro-Phe-pNA |
| Suc-Ala-Gly-Pro-Phe-pNA | C29H34N6O9 | 610.62 | 128802-77-7 | Suc-Ala-Gly-Pro-Phe-pNA |
| Suc-Ala-His-Pro-Phe-pNA | C33H38N8O9 | 690.71 | 128802-75-5 | Suc-Ala-His-Pro-Phe-pNA |
| Suc-Ala-Ile-Pro-Phe-pNA | C33H42N6O9 | 666.73 | 128802-79-9 | Suc-Ala-Ile-Pro-Phe-pNA |
| Suc-Ala-Lys-Pro-Phe-pNA | C33H43N7O9 | 681.75 | 128802-74-4 | Suc-Ala-Lys-Pro-Phe-pNA |
| Suc-Ala-Trp-Pro-Phe-pNA | C38H41N7O9 | 739.79 | 128822-32-2 | Suc-Ala-Trp-Pro-Phe-pNA |
| Suc-Ala-Val-Pro-Phe-pNA | C32H40N6O9 | 652.7 | 95192-38-4 | Suc-Ala-Val-Pro-Phe-pNA |
| T1, MSRPACPNDKYE | C58H91N17O20S2 | 1410.6 | 207553-92-2 | H-Met-Ser-Arg-Pro-Ala-Cys-Pro-Asn-Asp-Lys-Tyr-Glu-OH |
| C20H30N6O4 | 418.5 | 37553-80-3 | H-Phe-Pro-Arg-OH | |
| TFLLRamide, (Thr1)-TRAP-5 amide, (Thr1)-PAR-1 (1-5) amide (human) | C31H53N9O6 | 647.82 | 197794-83-5 | H-Thr-Phe-Leu-Leu-Arg-NH2 |
| TRAP-5, Thrombin Receptor Activator Peptide 5, PAR-1 (1-5) (human), Proteinase Activated Receptor 1 (1-5) (human), Thrombin Receptor (1-5) (human), Coagulation Factor II Receptor (1-5) (human), SFLLR | C30H50N8O7 | 634.78 | 141685-53-2 | H-Ser-Phe-Leu-Leu-Arg-OH |
| (Cit5)-TRAP-5, (Cit5)-Thrombin Receptor Activator Peptide 5, (Cit5)-PAR-1 (1-5) (human), (Cit5)-Proteinase Activated Receptor 1 (1-5) (human), (Cit5)-Thrombin Receptor (1-5) (human), (Cit5)-Coagulation Factor II Receptor (1-5) (human), SFLLCit | C30H49N7O8 | 635.76 | 287184-84-3 | H-Ser-Phe-Leu-Leu-Cit-OH |
| TRAP-5 amide, Thrombin Receptor Activator Peptide 5 amide, SFLLRamide, PAR-1 (1-5) amide (human), Proteinase Activated Receptor 1 (1-5) amide (human), Thrombin Receptor (1-5) amide (human), Coagulation Factor II Receptor (1-5) amide (human) | C30H51N9O6 | 633.79 | 141923-41-3 | H-Ser-Phe-Leu-Leu-Arg-NH2 |
| TRAP-6, Thrombin Receptor Activator Peptide 6, PAR-1 (1-6) (human), Proteinase Activated Receptor 1 (1-6) (human), Thrombin Receptor (1-6) (human), Coagulation Factor II Receptor (1-6) (human), SFLLRN | C34H56N10O9 | 748.88 | 141136-83-6 | H-Ser-Phe-Leu-Leu-Arg-Asn-OH |
| TRAP-6 amide, Thrombin Receptor Activator Peptide 6 amide, PAR-1 (1-6) amide (human), Proteinase Activated Receptor 1 (1-6) amide (human), Thrombin Receptor (1-6) amide (human), Coagulation Factor II Receptor (1-6) amide (human), SFLLRNamide | C34H57N11O8 | 747.9 | 141923-40-2 | H-Ser-Phe-Leu-Leu-Arg-Asn-NH2 |
| (DL-Isoser1)-TRAP-6, iso-TRAP, (DL-Isoser1)-Thrombin Receptor Activator Peptide 6, (DL-Isoser1)-PAR-1 (1-6) (human), (DL-Isoser1)-Proteinase Activated Receptor 1 (1-6) (human), (DL-Isoser1)-Thrombin Receptor 1 (1-6) (human) | C34H56N10O9 | 748.88 | 150242-29-8 | H-DL-Isoser-Phe-Leu-Leu-Arg-Asn-OH |
| (Phe1,Ser2)-TRAP-6, (Phe1,Ser2)-Thrombin Receptor Activator Peptide 6, (Phe1,Ser2)-PAR-1 (1-6) (human), (Phe1,Ser2)-Proteinase Activated Receptor 1 (1-6) (human), (Phe1,Ser2)-Thrombin Receptor 1 (1-6) (human), (Phe1,Ser2)-Coagulation Factor II Receptor (1-6) (human), FSLLRN | C34H56N10O9 | 748.88 | 374898-11-0 | H-Phe-Ser-Leu-Leu-Arg-Asn-OH |
| TRAP-6 (2-6), Thrombin Receptor Activator Peptide 6 (2-6), PAR-1 (2-6) (human), Proteinase Activated Receptor 1 (2-6) (human), Thrombin Receptor (2-6) (human), Coagulation Factor II Receptor (2-6) (human), FLLRN | C31H51N9O7 | 661.8 | 141136-84-7 | H-Phe-Leu-Leu-Arg-Asn-OH |
| TRAP-7, Thrombin Receptor Activator Peptide 7, PAR-1 (1-7) (human), Proteinase Activated Receptor 1 (1-7) (human), Thrombin Receptor (1-7) (human), Coagulation Factor II Receptor (1-7) (human), SFLLRNP | C39H63N11O10 | 846.01 | 145229-76-1 | H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-OH |
| (Tyr1)-TRAP-7, YFLLRNP, (Tyr1)-Thrombin Receptor Activator Peptide 7, (Tyr1)-PAR-1 (1-7) (human), (Tyr1)-Proteinase Activated Receptor 1 (1-7) (human), (Tyr1)-Thrombin Receptor (1-7) (human), (Tyr1)-Coagulation Factor II Receptor (1-7) (human) | C45H67N11O10 | 922.1 | 149440-16-4 | H-Tyr-Phe-Leu-Leu-Arg-Asn-Pro-OH |
| TRAP-14, Thrombin Receptor Activator Peptide 14, PAR-1 (1-14) (human), Proteinase Activated Receptor 1 (1-14) (human), Thrombin Receptor (1-14) (human), Coagulation Factor II Receptor (1-14) (human), SFLLRNPNDKYEPF | C81H118N20O23 | 1739.95 | 137339-65-2 | H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH |
| TRAP-14 amide, Thrombin Receptor Activator Peptide 14 amide, Proteinase Activated Receptor 1 (1-14) amide (human), PAR-1 (1-14) amide (human), Thrombin Receptor (1-14) amide (human), Coagulation Factor II Receptor (1-14) amide (human), SFLLRNPNDKYEPFamide | C81H119N21O22 | 1738.96 | 141923-36-6 | H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-NH2 |
| Hirullin | C68H96N14O29 | 1573.59 | 131147-81-4 | H-Ser-Asp-Phe-Glu-Glu-Phe-Ser-Leu-Asp-Asp-Ile-Glu-Gln-OH |
| C31H45N7O7 | 627.74 | 65147-04-8 | Boc-Val-Pro-Arg-AMC | |
| C37H43N7O6 | 681.79 | 88899-22-3 | Bz-Phe-Val-Arg-AMC | |
| C20H30N8O5 | 462.51 | 77695-30-8 | Sar-Pro-Arg-pNA | |
| Thrombin B-Chain (147-158) (human) | C54H84N16O18 | 1245.36 | 207553-42-2 | H-Thr-Trp-Thr-Ala-Asn-Val-Gly-Lys-Gly-Gln-Pro-Ser-OH |
| C28H33N7O7 | 579.57 | 102601-58-1 | Z-Gly-Gly-Arg-AMC | |
| C29H34N6O6 | 562.59 | 70375-23-4 | Z-Pro-Arg-AMC | |
| H-Ile-Arg-Val-Val-Met-OH | C27H52N8O6S | 616.83 | 149234-05-9 | H-Ile-Arg-Val-Val-Met-OH |
| H-Leu-Ser-Lys-Leu-OH | C21H41N5O6 | 459.59 | 162559-45-7 | H-Leu-Ser-Lys-Leu-OH |
本網(wǎng)頁所展示的有關(guān)【Gpant-1, Ptt-SP (4-11)_生化試劑_合肥賽曼諾生物科技有限公司】的信息/圖片/參數(shù)等由商一網(wǎng)的會員【合肥賽曼諾生物科技有限公司】提供，由商一網(wǎng)會員【合肥賽曼諾生物科技有限公司】自行對信息/圖片/參數(shù)等的真實性、準(zhǔn)確性和合法性負責(zé)，本平臺（本網(wǎng)站）僅提供展示服務(wù)，請謹慎交易，因交易而產(chǎn)生的法律關(guān)系及法律糾紛由您自行協(xié)商解決，本平臺（本網(wǎng)站）對此不承擔(dān)任何責(zé)任。您在本網(wǎng)頁可以瀏覽【Gpant-1, Ptt-SP (4-11)_生化試劑_合肥賽曼諾生物科技有限公司】有關(guān)的信息/圖片/價格等及提供【Gpant-1, Ptt-SP (4-11)_生化試劑_合肥賽曼諾生物科技有限公司】的商家公司簡介、聯(lián)系方式等信息。
在您的合法權(quán)益受到侵害時，歡迎您向郵箱發(fā)送郵件，或者進入《網(wǎng)站意見反饋》了解投訴處理流程，我們將竭誠為您服務(wù)，感謝您對商一網(wǎng)的關(guān)注與支持！
